Schraml, Peter

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

Posch, F., Silina, K., Leibl, S., Mündlein, A., Moch, H., Siebenhüner, A., Samaras, P., Riedl, J., Stotz, M., Szkandera, J., et al. (2018) · OncoImmunology

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 380

PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma

Ruf, M., Moch, H., & Schraml, P. (2016) · International Journal of Cancer

Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism

Cited by 179

Amplification pattern of 12q13–q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer

Simon, R., Struckmann, K., Schraml, P., Wagner, U., Forster, T., Moch, H., Fijan, A., Bruderer, J., Wilber, K., Mihatsch, M. J., et al. (2002) · Oncogene

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 157